Biosimulation Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026 Discovering and producing a lifesaving drug formula is a high-priced process. If the drug molecule fails at the last stage of development it can ruin efforts, time and money. This forged the need to develop a predictive tool that could foretell outcomes of drug development by simulating biological process to treat the desired ailment. This need serves as a significant catalyst in the growth of biosimulation market for the coming years. What is Biosimulation? Simulation of a biological process using computer aid and algorithms refers to Biosimulation. It supports the model-based prediction of dynamics of biological systems, for instance, the response of a single cell towards a substantial say in case of diabetic ailments. Advancement in biosimulation technologies, increase in healthcare expenditures and computer intelligence development contribute to additional factors other than the need for a predictive tool as aforementioned. The Global biosimulation market size is forecasted to reach over $5 billion by 2026 end from $1.65 billion in 2018. Thus it is estimated to register a CAGR of15.6% during the forecast period of 2019-2026. The biosimulation market can be categorised by product type, service type, end-users, and region. Pharmaceutical manufacturers, healthcare regulatory bodies and research organizations are actively investing in research and development of drug discovery by utilising biosimulation techniques for augmenting the efficacy of drug discovery and development process. Hence accelerated drug discovery process by these end users is one of the major drivers in biosimulation market growth. The goal to detect early sign of disease along with an overwhelming burden of genetic disorders leads to an increase in research funding in gene therapy. This implies higher chances of adoption of biosimulation products and services during the forecasted period. North America to Dominate the Market North America leads the market in terms of revenue due to factors such as high usage of personalized medicine, growth in the biotechnology and pharmaceutical industry, ongoing drug development processes, increasing R&D expenditure by pharmaceutical and biotechnology organisations. Europe holds the second position amongst dominating markets followed by the Asia Pacific region. Higher cost efficiency is one of the reasons for a surge in demand for biosimulation services. Contract services segment is expected to exhibit growth at a significant CAGR during the forecast period. Biosimulation provides information regarding dose precision, predicting drug safety, drug interaction on a molecular level and PBPK(physiologically-based pharmacokinetic) modelling using sophisticated pharmacodynamics models of the vital organs like heart, liver, and other organisms. Advanced simulation and instrumented tools offer high-fidelity, realistic, and immersive insights by combining cloud-based approach with simulation platforms (like Simcyp) and data visualization software using virtual patient population. Besides mergers and acquisitions among major players, the market exhibits promising lucrative progression trends during the forecast period. Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=69&page=requestsample Report Structure Global Biosimulation Market, by Product Type Contract Services Software In House Molecular Simulation Global Biosimulation Market, by Service Type Subscription-based Services Ownership Global Biosimulation Market, by End-User Biopharmaceutical Companies Contract Research Organization Academic Institutes Global Biosimulation Market, by Region Europe North America APAC Latin America Rest of World Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/requestsample.aspx?id=69&page=askfordiscount Competitive Landscape Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study To provide with an exhaustive analysis on the global biosimulation market, by service type, by end-user, and region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1. Introduction 1.1. Scope and Objective 1.2. Assumptions and Acronyms 1.3. Forecast Factors 1.4. Research Methodology 2. Executive Summary 2.1. Industry Cluster Analysis 2.2. Competition Matrix 2.3. Strategies Recommendations 3. Market Definition 3.1. Report Scope (Inclusions & Exclusions) 3.2. Market Segmentation 4. Global Biosimulation Market Overview 4.1. Global Biosimulation Market Revenue (USD Mn) 5. Key Inclusions 5.1. Porter’s Five Force analysis 5.2. Market Dynamics 5.3. Industry Trends 5.4. Regulatory Guidelines 5.5. Opportunities in Biosimulation 6. Competition Dynamics 6.1. Company Share Analysis (2018) 6.2. Top 10 Product Pricing by Region 7. Global Biosimulation Market Revenue (USD Mn), 2018-2026 by Service Type 7.1. Key Market Findings 7.2. Long Term ROI Segments 7.3. Revenue Opportunity Influencing Factors 7.4. Market Revenue (USD Mn) Assessment and Forecast by Service Type, 20182026 7.4.1 Subscriptionbased Services 7.4.2 Ownership 8. Global Biosimulation Market Revenue (USD Mn), 2018-2026 by End User 8.1. Key Market Findings 8.2. Long Term ROI Segments 8.3. Revenue Opportunity Influencing Factors 8.4. Market Revenue (USD Mn) Assessment and Forecast by End User, 20182026 8.4.1 BiopharmaceuticalCompanies 8.4.2 ContractResearch Organization 8.4.3 AcademicInstitutes 9. Global Biosimulation Market Revenue (USD Mn), 2018-2026 by Region 9.1. Key Market Findings 9.2. Long Term ROI Segments 9.3. Revenue Opportunity Influencing Factors 9.4. Market Revenue (USD Mn) Assessment and Forecast by Region,2026 9.4.1 North America 9.4.2 Latin America 9.4.3 Europe 9.4.4 Asia Pacific 9.4.5 Rest of world 10. North America Biosimulation Market Revenue (US$ Mn), 2018-2026 10.1. Key Market Findings 10.2. Long Term ROI Segments 10.3. Revenue Opportunity Influencing Factors 10.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 10.4.1 US 10.4.2 Canada 10.5. Market Revenue (USD Mn) Assessment and Forecast by Service Type, 2018-2026 10.5.3 Subscriptionbased Services 10.5.4 Ownership 10.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 10.6.5 BiopharmaceuticalCompanies 10.6.6 ContractResearch Organization 10.6.7 AcademicInstitutes 11. Latin America Biosimulation Market Revenue (US$ Mn), 2018-2026 11.1. Key Market Findings 11.2. Long Term ROI Segments 11.3. Revenue Opportunity Influencing Factors 11.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 11.4.1 Brazil 11.4.2 Mexico 11.4.3 Argentina 11.4.4 Rest of Latin America 11.5. Market Revenue (USD Mn) Assessment and Forecast by Service Type, 2018-2026 11.5.5 Subscriptionbased Services 11.5.6 Ownership 11.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 11.6.7 BiopharmaceuticalCompanies 11.6.8 ContractResearch Organization 11.6.9 AcademicInstitutes 12. Europe America Biosimulation Market Revenue (US$ Mn), 2018-2026 12.1. Key Market Findings 12.2. Long Term ROI Segments 12.3. Revenue Opportunity Influencing Factors 12.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 12.4.1 Germany 12.4.2 France 12.4.3 Spain 12.4.4 UK 12.4.5 Russia 12.4.6 Poland 12.4.7 Rest of Europe 12.5. Market Revenue (USD Mn) Assessment and Forecast by Service Type, 2018-2026 12.5.8 Subscriptionbased Services 12.5.9 Ownership 12.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 12.6.10BiopharmaceuticalCompanies 12.6.11ContractResearch Organization 12.6.12AcademicInstitutes 13. Asia Pacific America Biosimulation Market Revenue (US$ Mn), 2018-2026 13.1. Key Market Findings 13.2. Long Term ROI Segments 13.3. Revenue Opportunity Influencing Factors 13.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 13.4.1 Emerging Asia 13.4.1.1 China 13.4.1.2 India 13.4.1.3 ASEAN-5 13.4.1.4 Rest of Emerging Asia 13.4.2 Japan 13.5. Market Revenue (USD Mn) Assessment and Forecast by Service Type, 2018-2026 13.5.3 Subscriptionbased Services 13.5.4 Ownership 13.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 13.6.5 BiopharmaceuticalCompanies 13.6.6 ContractResearch Organization 13.6.7 AcademicInstitutes 14. Rest of World America Biosimulation Market Revenue (US$ Mn), 2018-2026 14.1. Key Market Findings 14.2. Long Term ROI Segments 14.3. Revenue Opportunity Influencing Factors 14.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 14.4.1 Middle East 14.4.2 South Africa 14.4.3 North Africa 14.4.4 Rest of World 14.5. Market Revenue (USD Mn) Assessment and Forecast by Service Type, 2018-2026 14.5.5 Subscriptionbased Services 14.5.6 Ownership 14.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 14.6.7 BiopharmaceuticalCompanies 14.6.8 ContractResearch Organization 14.6.9 AcademicInstitutes 15. Company Profiles 15.1. Competition Landscape 15.2. Global Company Share (USD Mn) Overview, 2018 15.3. Company Profiles 15.3.1 Schrödinger 15.3.1.1 Corporate Overview 15.3.1.2 Financial Performance 15.3.1.3 Peer Comparison & 3C marketing equation 15.3.1.4 Company Strategy & Channel Management 15.3.2 Simulation Plus 15.3.2.1 Corporate Overview 15.3.2.2 Financial Performance 15.3.2.3 Peer Comparison & 3C marketing equation 15.3.2.4 Company Strategy & Channel Management 15.3.3 INOSIM SoftwareDassault Systèmes 15.3.3.1 Corporate Overview 15.3.3.2 Financial Performance 15.3.3.3 Peer Comparison & 3C marketing equation 15.3.3.4 Company Strategy & Channel Management 15.3.4 LeadInvent Technologies 15.3.4.1 Corporate Overview 15.3.4.2 Financial Performance 15.3.4.3 Peer Comparison & 3C marketing equation 15.3.4.4 Company Strategy & Channel Management 15.3.5 Others 15.3.5.1 Corporate Overview 15.3.5.2 Financial Performance 15.3.5.3 Peer Comparison & 3C marketing equation 15.3.5.4 Company Strategy & Channel Management 16. Research Sources & Primary Verbatim Inquire further details about this report at: [email protected] About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: [email protected] Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com
Discovering and producing a lifesaving drug formula is a high-priced process. If the drug molecule fails at the last stage of development it can ruin efforts, time and money. This forged the need to develop a predictive tool that could foretell outcomes of drug development by simulating biological process to treat the desired ailment.
© Copyright 2024 Paperzz
